August 2022 News/Events

Software: GastroPlus®

Honoring World Lung Cancer Day
An estimated 236,740 people in the U.S. will be diagnosed with lung cancer in 2022. That’s 649 people each day27 people each hour, and one person every 2½ minutes.
To help accelerate global research efforts in support of finding a cure, Simulations Plus is happy to offer an exclusive software trial to the GastroPlus pulmonary model.

Check out the published case studies of the pulmonary model


Scientific Resources

Software Introduction: The GastroPlus® Additional Dosage Routes Seminar Series Pulmonary with John DiBella and Jim Mullin

Poster: Using Quantitative Systems Pharmacology Modeling to Understand the Pathophysiology of Idiopathic Pulmonary Fibrosis 

Article: Population pharmacokinetics (Pop PK) of MYL-1402O (a proposed biosimilar to bevacizumab) and reference product (Avastin) in patients with nonsquamous non-small cell lung cancer (nsNSCLC)

Video: Predicting optimal scheduling of drug combinations in lung cancer xenografts using a population PK/PD model

View Our Resource Center

Summer 2022

Scientific Conferences

Aug. 15-19, ISoP QSP Week, Virtual
  • DILIsym team will be in attendance
Aug. 21-25, ACS Fall, Chicago, IL
  • Bob Clark will present “AI-driven drug design (AIDD): Coupling high-throughput pharmacokinetic simulation (HTPK) to multi-objective molecular evolution of triazolopyrimidine antimalarial leads” on Wednesday, August 24th from 4:40 PM – 5:00 PM
See us next month at:

View Our Events Calendar

Beginner & Advanced



Complimentary Introduction to GastroPlus

  • Sept. 6
  • Oct. 10 [Course conducted in Central European Time]
  • Nov. 7
  • Dec. 5

GastroPlus Introductory Workshop 

  • Sept 26-30
  • Nov. 21-25 [Course conducted in Central European Time]

Advanced GastroPlus Workshop: DMPK and Clinical Pharmacology, Nov. 14-17

View All Workshops

Learn More About

Concierge Program

The Value of Strategic Partnership

Providing one-on-one support for our clients and partners as they navigate the long and winding road of model-informed drug discovery.

Meet Nate Musser, Director of Alliance Management.

Learn More

Join Us Live or Stream On Demand



Sept. 7, Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development – hosted by Tom Sun, in collaboration with the US FDA’s Dr. Brian P. Booth & Dr. Hao Zhu.

Sept. 14, GastroPlus® as an Educational Tool: Teaching of Pharmacokinetics and Biopharmaceutics through PBPK Modeling

Register for a Webinar

Stay Informed

Corporate News

In Case You Missed It #ICYMI
Employee Highlights

About Us

Copyright © 2022 Simulations Plus, All rights reserved.

Simulations Plus, Inc. Corporate Headquarters
42505 10th Street West
Lancaster, CA 93534
Telephone: +1-661-723-7723

Cognigen, a Simulations Plus division

500 Seneca Street, Suite 600
Buffalo, NY 14204
Telephone: +1-716-633-3463

DILIsym Services, a Simulations Plus division
Six Davis Drive
PO Box 12317
Research Triangle Park, NC 27709
Telephone: +1-919-558-1323

Lixoft, a Simulations Plus division
8 rue de la Renaissance Batiment D
92160 Antony, France
Telephone: +33 9 72 53 91 80